カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の複合グリチルリチン注射市場2022年：市場規模予測（～2028年）

■ 英語タイトル：Global Compound Glycyrrhizin Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR22NO19242）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR22NO19242
■ 発行日：2022年11月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品
■ ページ数：107
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥528,960見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥793,440見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,057,920見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の複合グリチルリチン注射市場2022年：市場規模予測（～2028年）]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

複合グリチルリチン注射市場レポートは、世界の市場規模、地域および国レベルの市場規模、セグメント市場の成長性、市場シェア、競争環境、販売分析、国内および世界の市場プレーヤーの影響、バリューチェーンの最適化、最近の動向、機会分析、市場成長の戦略的な分析、製品発売、地域市場の拡大などに関する情報を提供します。
GlobalInfoResearchの最新の調査によると、世界の複合グリチルリチン注射の市場規模は2021年のxxx米ドルから2028年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。

複合グリチルリチン注射市場は種類と用途によって区分されます。2017年～2028年において、量と金額の観点から種類別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

種類別セグメントは次をカバーします。
・静脈注射、点滴

用途別セグメントは次のように区分されます。
・病院調剤薬局、小売調剤薬局、その他

世界の複合グリチルリチン注射市場の主要な市場プレーヤーは以下のとおりです。
・Shanxi PUDE Pharmaceutical、Xi'an Lijun Pharmaceutical、Beijing Kawin Technology Share-Holding、CSPC OUYI Pharmaceutical、North China Pharmaceutical、Cisen Pharmaceutical、Harbin Medisan Pharmaceutical、Anhui Hongye Pharmaceutical、Reyoung Pharmaceutical、Chengdu Easton Bio Pharmaceuticals

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、複合グリチルリチン注射製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な複合グリチルリチン注射メーカーの企業概要、2019年～2022年までの複合グリチルリチン注射の価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な複合グリチルリチン注射メーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2017年～2028年までの地域別複合グリチルリチン注射の販売量、売上、成長性を示しています。
・第5、6章では、2017年～2028年までの複合グリチルリチン注射の種類別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2017年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2028年までの主要地域での複合グリチルリチン注射市場予測を収録しています。
・第12章では、主要な原材料、主要なサプライヤー、および複合グリチルリチン注射の産業チェーンを掲載しています。
・第13、14、15章では、複合グリチルリチン注射の販売チャネル、販売業者、顧客、調査結果と結論、付録、データソースなどについて説明します。

***** 目次(一部) *****

・市場概要
- 複合グリチルリチン注射の概要
- 種類別分析（2017年vs2021年vs2028年）：静脈注射、点滴
- 用途別分析（2017年vs2021年vs2028年）：病院調剤薬局、小売調剤薬局、その他
- 世界の複合グリチルリチン注射市場規模・予測
- 世界の複合グリチルリチン注射生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Shanxi PUDE Pharmaceutical、Xi'an Lijun Pharmaceutical、Beijing Kawin Technology Share-Holding、CSPC OUYI Pharmaceutical、North China Pharmaceutical、Cisen Pharmaceutical、Harbin Medisan Pharmaceutical、Anhui Hongye Pharmaceutical、Reyoung Pharmaceutical、Chengdu Easton Bio Pharmaceuticals
・メーカー別市場シェア・市場集中度
・地域別市場分析2017年-2028年
・種類別分析2017年-2028年：静脈注射、点滴
・用途別分析2017年-2028年：病院調剤薬局、小売調剤薬局、その他
・複合グリチルリチン注射の北米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・複合グリチルリチン注射のヨーロッパ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・複合グリチルリチン注射のアジア市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・複合グリチルリチン注射の南米市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・複合グリチルリチン注射の中東・アフリカ市場
- 種類別市場規模2017年-2028年
- 用途別市場規模2017年-2028年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Compound Glycyrrhizin Injection market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Compound Glycyrrhizin Injection market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during forecast period 2022-2028. Hospital Pharmacy accounting for % of the Compound Glycyrrhizin Injection global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Intravenous Injection segment is altered to a % CAGR between 2022 and 2028.
Global key manufacturers of Compound Glycyrrhizin Injection include Shanxi PUDE Pharmaceutical, Xi’an Lijun Pharmaceutical, Beijing Kawin Technology Share-Holding, CSPC OUYI Pharmaceutical, and North China Pharmaceutical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Compound Glycyrrhizin Injection market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Intravenous Injection
Intravenous Drip
Market segment by Application can be divided into
Hospital Pharmacy
Retail Pharmacy
Others
The key market players for global Compound Glycyrrhizin Injection market are listed below:
Shanxi PUDE Pharmaceutical
Xi’an Lijun Pharmaceutical
Beijing Kawin Technology Share-Holding
CSPC OUYI Pharmaceutical
North China Pharmaceutical
Cisen Pharmaceutical
Harbin Medisan Pharmaceutical
Anhui Hongye Pharmaceutical
Reyoung Pharmaceutical
Chengdu Easton Bio Pharmaceuticals
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Compound Glycyrrhizin Injection product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Compound Glycyrrhizin Injection, with price, sales, revenue and global market share of Compound Glycyrrhizin Injection from 2019 to 2022.
Chapter 3, the Compound Glycyrrhizin Injection competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Compound Glycyrrhizin Injection breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2017 to 2028.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2017 to 2022.and Compound Glycyrrhizin Injection market forecast, by regions, type and application, with sales and revenue, from 2023 to 2028.
Chapter 12, the key raw materials and key suppliers, and industry chain of Compound Glycyrrhizin Injection.
Chapter 13, 14, and 15, to describe Compound Glycyrrhizin Injection sales channel, distributors, customers, research findings and conclusion, appendix and data source.

*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Compound Glycyrrhizin Injection Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Compound Glycyrrhizin Injection Revenue by Type: 2017 Versus 2021 Versus 2028
1.2.2 Intravenous Injection
1.2.3 Intravenous Drip
1.3 Market Analysis by Application
1.3.1 Overview: Global Compound Glycyrrhizin Injection Revenue by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Global Compound Glycyrrhizin Injection Market Size & Forecast
1.4.1 Global Compound Glycyrrhizin Injection Sales in Value (2017 & 2021 & 2028)
1.4.2 Global Compound Glycyrrhizin Injection Sales in Volume (2017-2028)
1.4.3 Global Compound Glycyrrhizin Injection Price (2017-2028)
1.5 Global Compound Glycyrrhizin Injection Production Capacity Analysis
1.5.1 Global Compound Glycyrrhizin Injection Total Production Capacity (2017-2028)
1.5.2 Global Compound Glycyrrhizin Injection Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Compound Glycyrrhizin Injection Market Drivers
1.6.2 Compound Glycyrrhizin Injection Market Restraints
1.6.3 Compound Glycyrrhizin Injection Trends Analysis
2 Manufacturers Profiles
2.1 Shanxi PUDE Pharmaceutical
2.1.1 Shanxi PUDE Pharmaceutical Details
2.1.2 Shanxi PUDE Pharmaceutical Major Business
2.1.3 Shanxi PUDE Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.1.4 Shanxi PUDE Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2 Xi’an Lijun Pharmaceutical
2.2.1 Xi’an Lijun Pharmaceutical Details
2.2.2 Xi’an Lijun Pharmaceutical Major Business
2.2.3 Xi’an Lijun Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.2.4 Xi’an Lijun Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3 Beijing Kawin Technology Share-Holding
2.3.1 Beijing Kawin Technology Share-Holding Details
2.3.2 Beijing Kawin Technology Share-Holding Major Business
2.3.3 Beijing Kawin Technology Share-Holding Compound Glycyrrhizin Injection Product and Services
2.3.4 Beijing Kawin Technology Share-Holding Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4 CSPC OUYI Pharmaceutical
2.4.1 CSPC OUYI Pharmaceutical Details
2.4.2 CSPC OUYI Pharmaceutical Major Business
2.4.3 CSPC OUYI Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.4.4 CSPC OUYI Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5 North China Pharmaceutical
2.5.1 North China Pharmaceutical Details
2.5.2 North China Pharmaceutical Major Business
2.5.3 North China Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.5.4 North China Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6 Cisen Pharmaceutical
2.6.1 Cisen Pharmaceutical Details
2.6.2 Cisen Pharmaceutical Major Business
2.6.3 Cisen Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.6.4 Cisen Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7 Harbin Medisan Pharmaceutical
2.7.1 Harbin Medisan Pharmaceutical Details
2.7.2 Harbin Medisan Pharmaceutical Major Business
2.7.3 Harbin Medisan Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.7.4 Harbin Medisan Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8 Anhui Hongye Pharmaceutical
2.8.1 Anhui Hongye Pharmaceutical Details
2.8.2 Anhui Hongye Pharmaceutical Major Business
2.8.3 Anhui Hongye Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.8.4 Anhui Hongye Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9 Reyoung Pharmaceutical
2.9.1 Reyoung Pharmaceutical Details
2.9.2 Reyoung Pharmaceutical Major Business
2.9.3 Reyoung Pharmaceutical Compound Glycyrrhizin Injection Product and Services
2.9.4 Reyoung Pharmaceutical Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10 Chengdu Easton Bio Pharmaceuticals
2.10.1 Chengdu Easton Bio Pharmaceuticals Details
2.10.2 Chengdu Easton Bio Pharmaceuticals Major Business
2.10.3 Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin Injection Product and Services
2.10.4 Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin Injection Sales, Price, Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
3 Compound Glycyrrhizin Injection Breakdown Data by Manufacturer
3.1 Global Compound Glycyrrhizin Injection Sales in Volume by Manufacturer (2019, 2020, 2021, and 2022)
3.2 Global Compound Glycyrrhizin Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022)
3.3 Key Manufacturer Market Position in Compound Glycyrrhizin Injection
3.4 Market Concentration Rate
3.4.1 Top 3 Compound Glycyrrhizin Injection Manufacturer Market Share in 2021
3.4.2 Top 6 Compound Glycyrrhizin Injection Manufacturer Market Share in 2021
3.5 Global Compound Glycyrrhizin Injection Production Capacity by Company: 2021 VS 2022
3.6 Manufacturer by Geography: Head Office and Compound Glycyrrhizin Injection Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Compound Glycyrrhizin Injection Market Size by Region
4.1.1 Global Compound Glycyrrhizin Injection Sales in Volume by Region (2017-2028)
4.1.2 Global Compound Glycyrrhizin Injection Revenue by Region (2017-2028)
4.2 North America Compound Glycyrrhizin Injection Revenue (2017-2028)
4.3 Europe Compound Glycyrrhizin Injection Revenue (2017-2028)
4.4 Asia-Pacific Compound Glycyrrhizin Injection Revenue (2017-2028)
4.5 South America Compound Glycyrrhizin Injection Revenue (2017-2028)
4.6 Middle East and Africa Compound Glycyrrhizin Injection Revenue (2017-2028)
5 Market Segment by Type
5.1 Global Compound Glycyrrhizin Injection Sales in Volume by Type (2017-2028)
5.2 Global Compound Glycyrrhizin Injection Revenue by Type (2017-2028)
5.3 Global Compound Glycyrrhizin Injection Price by Type (2017-2028)
6 Market Segment by Application
6.1 Global Compound Glycyrrhizin Injection Sales in Volume by Application (2017-2028)
6.2 Global Compound Glycyrrhizin Injection Revenue by Application (2017-2028)
6.3 Global Compound Glycyrrhizin Injection Price by Application (2017-2028)
7 North America by Country, by Type, and by Application
7.1 North America Compound Glycyrrhizin Injection Sales by Type (2017-2028)
7.2 North America Compound Glycyrrhizin Injection Sales by Application (2017-2028)
7.3 North America Compound Glycyrrhizin Injection Market Size by Country
7.3.1 North America Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
7.3.2 North America Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
7.3.3 United States Market Size and Forecast (2017-2028)
7.3.4 Canada Market Size and Forecast (2017-2028)
7.3.5 Mexico Market Size and Forecast (2017-2028)
8 Europe by Country, by Type, and by Application
8.1 Europe Compound Glycyrrhizin Injection Sales by Type (2017-2028)
8.2 Europe Compound Glycyrrhizin Injection Sales by Application (2017-2028)
8.3 Europe Compound Glycyrrhizin Injection Market Size by Country
8.3.1 Europe Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
8.3.2 Europe Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
8.3.3 Germany Market Size and Forecast (2017-2028)
8.3.4 France Market Size and Forecast (2017-2028)
8.3.5 United Kingdom Market Size and Forecast (2017-2028)
8.3.6 Russia Market Size and Forecast (2017-2028)
8.3.7 Italy Market Size and Forecast (2017-2028)
9 Asia-Pacific by Region, by Type, and by Application
9.1 Asia-Pacific Compound Glycyrrhizin Injection Sales by Type (2017-2028)
9.2 Asia-Pacific Compound Glycyrrhizin Injection Sales by Application (2017-2028)
9.3 Asia-Pacific Compound Glycyrrhizin Injection Market Size by Region
9.3.1 Asia-Pacific Compound Glycyrrhizin Injection Sales in Volume by Region (2017-2028)
9.3.2 Asia-Pacific Compound Glycyrrhizin Injection Revenue by Region (2017-2028)
9.3.3 China Market Size and Forecast (2017-2028)
9.3.4 Japan Market Size and Forecast (2017-2028)
9.3.5 Korea Market Size and Forecast (2017-2028)
9.3.6 India Market Size and Forecast (2017-2028)
9.3.7 Southeast Asia Market Size and Forecast (2017-2028)
9.3.8 Australia Market Size and Forecast (2017-2028)
10 South America by Region, by Type, and by Application
10.1 South America Compound Glycyrrhizin Injection Sales by Type (2017-2028)
10.2 South America Compound Glycyrrhizin Injection Sales by Application (2017-2028)
10.3 South America Compound Glycyrrhizin Injection Market Size by Country
10.3.1 South America Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
10.3.2 South America Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
10.3.3 Brazil Market Size and Forecast (2017-2028)
10.3.4 Argentina Market Size and Forecast (2017-2028)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Compound Glycyrrhizin Injection Sales by Type (2017-2028)
11.2 Middle East & Africa Compound Glycyrrhizin Injection Sales by Application (2017-2028)
11.3 Middle East & Africa Compound Glycyrrhizin Injection Market Size by Country
11.3.1 Middle East & Africa Compound Glycyrrhizin Injection Sales in Volume by Country (2017-2028)
11.3.2 Middle East & Africa Compound Glycyrrhizin Injection Revenue by Country (2017-2028)
11.3.3 Turkey Market Size and Forecast (2017-2028)
11.3.4 Egypt Market Size and Forecast (2017-2028)
11.3.5 Saudi Arabia Market Size and Forecast (2017-2028)
11.3.6 South Africa Market Size and Forecast (2017-2028)
12 Raw Material and Industry Chain
12.1 Raw Material of Compound Glycyrrhizin Injection and Key Manufacturers
12.2 Manufacturing Costs Percentage of Compound Glycyrrhizin Injection
12.3 Compound Glycyrrhizin Injection Production Process
12.4 Compound Glycyrrhizin Injection Industrial Chain
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Compound Glycyrrhizin Injection Typical Distributors
13.3 Compound Glycyrrhizin Injection Typical Customers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Research Process and Data Source
15.3 Disclaimer

List of Tables
Table 1. Global Compound Glycyrrhizin Injection Revenue by Type, (USD Million), 2017 & 2021 & 2028
Table 2. Global Compound Glycyrrhizin Injection Revenue by Application, (USD Million), 2017 & 2021 & 2028
Table 3. Shanxi PUDE Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 4. Shanxi PUDE Pharmaceutical Major Business
Table 5. Shanxi PUDE Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 6. Shanxi PUDE Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 7. Xi'an Lijun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 8. Xi'an Lijun Pharmaceutical Major Business
Table 9. Xi'an Lijun Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 10. Xi'an Lijun Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 11. Beijing Kawin Technology Share-Holding Basic Information, Manufacturing Base and Competitors
Table 12. Beijing Kawin Technology Share-Holding Major Business
Table 13. Beijing Kawin Technology Share-Holding Compound Glycyrrhizin Injection Product and Services
Table 14. Beijing Kawin Technology Share-Holding Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 15. CSPC OUYI Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 16. CSPC OUYI Pharmaceutical Major Business
Table 17. CSPC OUYI Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 18. CSPC OUYI Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 19. North China Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 20. North China Pharmaceutical Major Business
Table 21. North China Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 22. North China Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 23. Cisen Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 24. Cisen Pharmaceutical Major Business
Table 25. Cisen Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 26. Cisen Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 27. Harbin Medisan Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 28. Harbin Medisan Pharmaceutical Major Business
Table 29. Harbin Medisan Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 30. Harbin Medisan Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 31. Anhui Hongye Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Anhui Hongye Pharmaceutical Major Business
Table 33. Anhui Hongye Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 34. Anhui Hongye Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 35. Reyoung Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 36. Reyoung Pharmaceutical Major Business
Table 37. Reyoung Pharmaceutical Compound Glycyrrhizin Injection Product and Services
Table 38. Reyoung Pharmaceutical Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 39. Chengdu Easton Bio Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 40. Chengdu Easton Bio Pharmaceuticals Major Business
Table 41. Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin Injection Product and Services
Table 42. Chengdu Easton Bio Pharmaceuticals Compound Glycyrrhizin Injection Sales (K Units), Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 43. Global Compound Glycyrrhizin Injection Sales by Manufacturer (2019, 2020, 2021, and 2022) & (K Units)
Table 44. Global Compound Glycyrrhizin Injection Revenue by Manufacturer (2019, 2020, 2021, and 2022) & (USD Million)
Table 45. Market Position of Manufacturers in Compound Glycyrrhizin Injection, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2021
Table 46. Global Compound Glycyrrhizin Injection Production Capacity by Company, (K Units): 2020 VS 2021
Table 47. Head Office and Compound Glycyrrhizin Injection Production Site of Key Manufacturer
Table 48. Compound Glycyrrhizin Injection New Entrant and Capacity Expansion Plans
Table 49. Compound Glycyrrhizin Injection Mergers & Acquisitions in the Past Five Years
Table 50. Global Compound Glycyrrhizin Injection Sales by Region (2017-2022) & (K Units)
Table 51. Global Compound Glycyrrhizin Injection Sales by Region (2023-2028) & (K Units)
Table 52. Global Compound Glycyrrhizin Injection Revenue by Region (2017-2022) & (USD Million)
Table 53. Global Compound Glycyrrhizin Injection Revenue by Region (2023-2028) & (USD Million)
Table 54. Global Compound Glycyrrhizin Injection Sales by Type (2017-2022) & (K Units)
Table 55. Global Compound Glycyrrhizin Injection Sales by Type (2023-2028) & (K Units)
Table 56. Global Compound Glycyrrhizin Injection Revenue by Type (2017-2022) & (USD Million)
Table 57. Global Compound Glycyrrhizin Injection Revenue by Type (2023-2028) & (USD Million)
Table 58. Global Compound Glycyrrhizin Injection Price by Type (2017-2022) & (US$/Unit)
Table 59. Global Compound Glycyrrhizin Injection Price by Type (2023-2028) & (US$/Unit)
Table 60. Global Compound Glycyrrhizin Injection Sales by Application (2017-2022) & (K Units)
Table 61. Global Compound Glycyrrhizin Injection Sales by Application (2023-2028) & (K Units)
Table 62. Global Compound Glycyrrhizin Injection Revenue by Application (2017-2022) & (USD Million)
Table 63. Global Compound Glycyrrhizin Injection Revenue by Application (2023-2028) & (USD Million)
Table 64. Global Compound Glycyrrhizin Injection Price by Application (2017-2022) & (US$/Unit)
Table 65. Global Compound Glycyrrhizin Injection Price by Application (2023-2028) & (US$/Unit)
Table 66. North America Compound Glycyrrhizin Injection Sales by Country (2017-2022) & (K Units)
Table 67. North America Compound Glycyrrhizin Injection Sales by Country (2023-2028) & (K Units)
Table 68. North America Compound Glycyrrhizin Injection Revenue by Country (2017-2022) & (USD Million)
Table 69. North America Compound Glycyrrhizin Injection Revenue by Country (2023-2028) & (USD Million)
Table 70. North America Compound Glycyrrhizin Injection Sales by Type (2017-2022) & (K Units)
Table 71. North America Compound Glycyrrhizin Injection Sales by Type (2023-2028) & (K Units)
Table 72. North America Compound Glycyrrhizin Injection Sales by Application (2017-2022) & (K Units)
Table 73. North America Compound Glycyrrhizin Injection Sales by Application (2023-2028) & (K Units)
Table 74. Europe Compound Glycyrrhizin Injection Sales by Country (2017-2022) & (K Units)
Table 75. Europe Compound Glycyrrhizin Injection Sales by Country (2023-2028) & (K Units)
Table 76. Europe Compound Glycyrrhizin Injection Revenue by Country (2017-2022) & (USD Million)
Table 77. Europe Compound Glycyrrhizin Injection Revenue by Country (2023-2028) & (USD Million)
Table 78. Europe Compound Glycyrrhizin Injection Sales by Type (2017-2022) & (K Units)
Table 79. Europe Compound Glycyrrhizin Injection Sales by Type (2023-2028) & (K Units)
Table 80. Europe Compound Glycyrrhizin Injection Sales by Application (2017-2022) & (K Units)
Table 81. Europe Compound Glycyrrhizin Injection Sales by Application (2023-2028) & (K Units)
Table 82. Asia-Pacific Compound Glycyrrhizin Injection Sales by Region (2017-2022) & (K Units)
Table 83. Asia-Pacific Compound Glycyrrhizin Injection Sales by Region (2023-2028) & (K Units)
Table 84. Asia-Pacific Compound Glycyrrhizin Injection Revenue by Region (2017-2022) & (USD Million)
Table 85. Asia-Pacific Compound Glycyrrhizin Injection Revenue by Region (2023-2028) & (USD Million)
Table 86. Asia-Pacific Compound Glycyrrhizin Injection Sales by Type (2017-2022) & (K Units)
Table 87. Asia-Pacific Compound Glycyrrhizin Injection Sales by Type (2023-2028) & (K Units)
Table 88. Asia-Pacific Compound Glycyrrhizin Injection Sales by Application (2017-2022) & (K Units)
Table 89. Asia-Pacific Compound Glycyrrhizin Injection Sales by Application (2023-2028) & (K Units)
Table 90. South America Compound Glycyrrhizin Injection Sales by Country (2017-2022) & (K Units)
Table 91. South America Compound Glycyrrhizin Injection Sales by Country (2023-2028) & (K Units)
Table 92. South America Compound Glycyrrhizin Injection Revenue by Country (2017-2022) & (USD Million)
Table 93. South America Compound Glycyrrhizin Injection Revenue by Country (2023-2028) & (USD Million)
Table 94. South America Compound Glycyrrhizin Injection Sales by Type (2017-2022) & (K Units)
Table 95. South America Compound Glycyrrhizin Injection Sales by Type (2023-2028) & (K Units)
Table 96. South America Compound Glycyrrhizin Injection Sales by Application (2017-2022) & (K Units)
Table 97. South America Compound Glycyrrhizin Injection Sales by Application (2023-2028) & (K Units)
Table 98. Middle East & Africa Compound Glycyrrhizin Injection Sales by Region (2017-2022) & (K Units)
Table 99. Middle East & Africa Compound Glycyrrhizin Injection Sales by Region (2023-2028) & (K Units)
Table 100. Middle East & Africa Compound Glycyrrhizin Injection Revenue by Region (2017-2022) & (USD Million)
Table 101. Middle East & Africa Compound Glycyrrhizin Injection Revenue by Region (2023-2028) & (USD Million)
Table 102. Middle East & Africa Compound Glycyrrhizin Injection Sales by Type (2017-2022) & (K Units)
Table 103. Middle East & Africa Compound Glycyrrhizin Injection Sales by Type (2023-2028) & (K Units)
Table 104. Middle East & Africa Compound Glycyrrhizin Injection Sales by Application (2017-2022) & (K Units)
Table 105. Middle East & Africa Compound Glycyrrhizin Injection Sales by Application (2023-2028) & (K Units)
Table 106. Compound Glycyrrhizin Injection Raw Material
Table 107. Key Manufacturers of Compound Glycyrrhizin Injection Raw Materials
Table 108. Direct Channel Pros & Cons
Table 109. Indirect Channel Pros & Cons
Table 110. Compound Glycyrrhizin Injection Typical Distributors
Table 111. Compound Glycyrrhizin Injection Typical Customers
List of Figures
Figure 1. Compound Glycyrrhizin Injection Picture
Figure 2. Global Compound Glycyrrhizin Injection Revenue Market Share by Type in 2021
Figure 3. Intravenous Injection
Figure 4. Intravenous Drip
Figure 5. Global Compound Glycyrrhizin Injection Revenue Market Share by Application in 2021
Figure 6. Hospital Pharmacy
Figure 7. Retail Pharmacy
Figure 8. Others
Figure 9. Global Compound Glycyrrhizin Injection Revenue, (USD Million) & (K Units): 2017 & 2021 & 2028
Figure 10. Global Compound Glycyrrhizin Injection Revenue and Forecast (2017-2028) & (USD Million)
Figure 11. Global Compound Glycyrrhizin Injection Sales (2017-2028) & (K Units)
Figure 12. Global Compound Glycyrrhizin Injection Price (2017-2028) & (US$/Unit)
Figure 13. Global Compound Glycyrrhizin Injection Production Capacity (2017-2028) & (K Units)
Figure 14. Global Compound Glycyrrhizin Injection Production Capacity by Geographic Region: 2022 VS 2028
Figure 15. Compound Glycyrrhizin Injection Market Drivers
Figure 16. Compound Glycyrrhizin Injection Market Restraints
Figure 17. Compound Glycyrrhizin Injection Market Trends
Figure 18. Global Compound Glycyrrhizin Injection Sales Market Share by Manufacturer in 2021
Figure 19. Global Compound Glycyrrhizin Injection Revenue Market Share by Manufacturer in 2021
Figure 20. Compound Glycyrrhizin Injection Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2021
Figure 21. Top 3 Compound Glycyrrhizin Injection Manufacturer (Revenue) Market Share in 2021
Figure 22. Top 6 Compound Glycyrrhizin Injection Manufacturer (Revenue) Market Share in 2021
Figure 23. Global Compound Glycyrrhizin Injection Sales Market Share by Region (2017-2028)
Figure 24. Global Compound Glycyrrhizin Injection Revenue Market Share by Region (2017-2028)
Figure 25. North America Compound Glycyrrhizin Injection Revenue (2017-2028) & (USD Million)
Figure 26. Europe Compound Glycyrrhizin Injection Revenue (2017-2028) & (USD Million)
Figure 27. Asia-Pacific Compound Glycyrrhizin Injection Revenue (2017-2028) & (USD Million)
Figure 28. South America Compound Glycyrrhizin Injection Revenue (2017-2028) & (USD Million)
Figure 29. Middle East & Africa Compound Glycyrrhizin Injection Revenue (2017-2028) & (USD Million)
Figure 30. Global Compound Glycyrrhizin Injection Sales Market Share by Type (2017-2028)
Figure 31. Global Compound Glycyrrhizin Injection Revenue Market Share by Type (2017-2028)
Figure 32. Global Compound Glycyrrhizin Injection Price by Type (2017-2028) & (US$/Unit)
Figure 33. Global Compound Glycyrrhizin Injection Sales Market Share by Application (2017-2028)
Figure 34. Global Compound Glycyrrhizin Injection Revenue Market Share by Application (2017-2028)
Figure 35. Global Compound Glycyrrhizin Injection Price by Application (2017-2028) & (US$/Unit)
Figure 36. North America Compound Glycyrrhizin Injection Sales Market Share by Type (2017-2028)
Figure 37. North America Compound Glycyrrhizin Injection Sales Market Share by Application (2017-2028)
Figure 38. North America Compound Glycyrrhizin Injection Sales Market Share by Country (2017-2028)
Figure 39. North America Compound Glycyrrhizin Injection Revenue Market Share by Country (2017-2028)
Figure 40. United States Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 41. Canada Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 42. Mexico Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 43. Europe Compound Glycyrrhizin Injection Sales Market Share by Type (2017-2028)
Figure 44. Europe Compound Glycyrrhizin Injection Sales Market Share by Application (2017-2028)
Figure 45. Europe Compound Glycyrrhizin Injection Sales Market Share by Country (2017-2028)
Figure 46. Europe Compound Glycyrrhizin Injection Revenue Market Share by Country (2017-2028)
Figure 47. Germany Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 48. France Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 49. United Kingdom Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 50. Russia Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Italy Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Asia-Pacific Compound Glycyrrhizin Injection Sales Market Share by Region (2017-2028)
Figure 53. Asia-Pacific Compound Glycyrrhizin Injection Sales Market Share by Application (2017-2028)
Figure 54. Asia-Pacific Compound Glycyrrhizin Injection Sales Market Share by Region (2017-2028)
Figure 55. Asia-Pacific Compound Glycyrrhizin Injection Revenue Market Share by Region (2017-2028)
Figure 56. China Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Japan Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Korea Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. India Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Southeast Asia Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Australia Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. South America Compound Glycyrrhizin Injection Sales Market Share by Type (2017-2028)
Figure 63. South America Compound Glycyrrhizin Injection Sales Market Share by Application (2017-2028)
Figure 64. South America Compound Glycyrrhizin Injection Sales Market Share by Country (2017-2028)
Figure 65. South America Compound Glycyrrhizin Injection Revenue Market Share by Country (2017-2028)
Figure 66. Brazil Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. Argentina Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Middle East & Africa Compound Glycyrrhizin Injection Sales Market Share by Type (2017-2028)
Figure 69. Middle East & Africa Compound Glycyrrhizin Injection Sales Market Share by Application (2017-2028)
Figure 70. Middle East & Africa Compound Glycyrrhizin Injection Sales Market Share by Region (2017-2028)
Figure 71. Middle East & Africa Compound Glycyrrhizin Injection Revenue Market Share by Region (2017-2028)
Figure 72. Turkey Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Egypt Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Saudi Arabia Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South Africa Compound Glycyrrhizin Injection Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. Manufacturing Cost Structure Analysis of Compound Glycyrrhizin Injection in 2021
Figure 77. Manufacturing Process Analysis of Compound Glycyrrhizin Injection
Figure 78. Compound Glycyrrhizin Injection Industrial Chain
Figure 79. Sales Channel: Direct Channel vs Indirect Channel
Figure 80. Methodology
Figure 81. Research Process and Data Source


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 注射用ヒアルロン酸ナトリウム化合物溶液のグローバル市場展望 2023年-2029年：単相溶液、二相溶液
  • 世界の双黄連（SHL）注射市場2022年：市場規模予測（～2028年）
  • 世界の複合炭酸カルシウム発泡性顆粒市場2022年：市場規模予測（～2028年）
  • 世界の漢方注射市場2022年：市場規模予測（～2028年）
  • 世界のクリスビタ注射市場2022年：市場規模予測（～2028年）
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR22NO19242 )"世界の複合グリチルリチン注射市場2022年：市場規模予測（～2028年）" (英文：Global Compound Glycyrrhizin Injection Market 2022 by Manufacturers, Regions, Type and Application, Forecast to 2028)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。